Literature DB >> 10192435

Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients.

C Lass-Flörl1, G M Salzer, T Schmid, W Rabl, H Ulmer, M P Dierichi.   

Abstract

Samples of lung tissues were obtained and analysed for Aspergillus carriage in 56 patients undergoing thoracic surgical intervention and 18 people who had an unexpected death. Out of 74 samples, 46 (63%) had evidence of pulmonary fungal colonization. The surgery population had a rate of 62% of fungal growth. Aspergillus was present in 39%. The autopsy population had a rate of 61% of fungal colonization. Aspergillus was present in 41%. In these cases eradication of fungal spores residing in the lung prior to aggressive chemotherapy and prevention of further spore uptake during hospitalization is indispensable in preventing pulmonary aspergillosis.

Entities:  

Mesh:

Year:  1999        PMID: 10192435     DOI: 10.1046/j.1365-2141.1999.01260.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Antifungal susceptibility and pathogenic potential of environmental isolated filamentous fungi compared with colonizing agents in immunocompromised patients.

Authors:  A B A Teixeira; M Silva; L Lyra; E A Luz; J Uno; H Takada; M Miyaji; K Nishimura; A Z Schreiber
Journal:  Mycopathologia       Date:  2005-09       Impact factor: 2.574

Review 2.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

3.  Prevalence of Aspergillus fumigatus skin positivity in adults without an apparent/known atopic disease in Uganda.

Authors:  Richard Kwizera; Felix Bongomin; Ronald Olum; William Worodria; Freddie Bwanga; David B Meya; Bruce J Kirenga; Robin Gore; Stephen J Fowler; David W Denning
Journal:  Ther Adv Infect Dis       Date:  2021-08-12

4.  High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.

Authors:  David W Denning; Steven Park; Cornelia Lass-Florl; Marcin G Fraczek; Marie Kirwan; Robin Gore; Jaclyn Smith; Ahmed Bueid; Caroline B Moore; Paul Bowyer; David S Perlin
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 5.  Blood Aspergillus PCR: The Good, the Bad, and the Ugly.

Authors:  Matthias Egger; Jeffrey D Jenks; Martin Hoenigl; Juergen Prattes
Journal:  J Fungi (Basel)       Date:  2020-01-27

Review 6.  Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.

Authors:  Valliappan Muthu; Ritesh Agarwal; Atul Patel; Soundappan Kathirvel; Ooriapadickal Cherian Abraham; Ashutosh Nath Aggarwal; Amanjit Bal; Ashu Seith Bhalla; Prashant N Chhajed; Dhruva Chaudhry; Mandeep Garg; Randeep Guleria; Ram Gopal Krishnan; Arvind Kumar; Uma Maheshwari; Ravindra Mehta; Anant Mohan; Alok Nath; Dharmesh Patel; Shivaprakash Mandya Rudramurthy; Puneet Saxena; Nandini Sethuraman; Tanu Singhal; Rajeev Soman; Balamugesh Thangakunam; George M Varghese; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2022-04-04       Impact factor: 71.421

Review 7.  Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.

Authors:  Georg Maschmeyer; Antje Haas; Oliver A Cornely
Journal:  Drugs       Date:  2007       Impact factor: 11.431

8.  Invasive aspergillosis successfully treated by combined antifungal therapy and immunosuppressive monotherapy two months following heart transplantation.

Authors:  Tomasz Urbanowicz; Bartłomiej Żabicki; Hanna Baszyńska-Wachowiak; Ewa Straburzyńska-Migaj; Robert Juszkat; Stefan Grajek; Marek Jemielity
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-06-30

9.  Mutations in EEA1 are associated with allergic bronchopulmonary aspergillosis and affect phagocytosis of Aspergillus fumigatus by human macrophages.

Authors:  Nicola L D Overton; Axel A Brakhage; Andreas Thywißen; David W Denning; Paul Bowyer
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.